One Disease, Two Lives: Exploring the Treatment of Breast Cancer During Pregnancy

Alexa G. Visco

Lara C. Meyer

Shuo Xi

Carlton G. Brown

pregnancy, breast cancer
CJON 2009, 13(4), 426-432. DOI: 10.1188/09.CJON.426-432

Because breast cancer risk increases with age and women in the United States continue to delay childbirth, the incidence of breast cancer during pregnancy will rise. About 10% of patients younger than age 40 diagnosed with breast cancer are pregnant. Historically, labor-delivery and oncology, the two spheres of clinical care, rarely overlapped. However, breast cancer occurs in about 1 in 3,000 pregnancies. Case studies suggest that the administration of chemotherapeutic agents during the second and third trimesters may be safe for the mother and fetus. Three specific case studies of pregnant women with cancer who received treatment are presented to identify the issues of cancer during pregnancy. Outcomes of infants who received chemotherapy in utero and associated nursing implications also are explored.

Jump to a section


    American Cancer Society. (2008). Breast cancer facts and figures 2007-2008. Retrieved April 15, 2009, from
    American Pregnancy Association. (2009). Statistics. Retrieved June 29, 2009, from
    Aviles, A., & Neri, N. (2001). Hematologic malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clinical Lymphoma, 2(3), 173-177.
    Azim, H.A., Jr., & Peccatori, F.A. (2008). Treatment of metastatic breast cancer during pregnancy: We need to talk! Breast, 17(4), 426-428.
    Bader, A.A., Schlembach, D., Tamussino, K.F., Pristauz, G., & Petru, E. (2007). Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncology, 8(1), 79-81.
    Beck, C.T. (2002). Theoretical perspectives of postpartum depression and their treatment implications. American Journal of Maternal Child Nursing, 27(5), 28-37.
    Berry, D.L., Theriault, R.L., Holmes, F.A., Parisi, V.M., Booser, D.J., Singletary, S.E., et al. (1999). Management of breast cancer during pregnancy using a standardized protocol. Journal of Clinical, 17(3), 855-861.
    Bonneterre, J., Roché, H., Monnier, A., Guastalla, J.P., Namer, M., Fargeot, P., et al. (2002). Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure. British Journal of Cancer, 87(11), 1210-1215.
    Burns, N., & Grove, S.K. (2005). The practice of nursing research: Conduct, critique, and utilization (5th ed.). St. Louis, MO: Elsevier Saunders.
    Cardonick, E., & Iacobucci, A. (2004). Use of chemotherapy during human pregnancy. Lancet Oncology, 5(5), 283-291.
    Centers for Disease Control and Prevention. (2007). Risk of breast cancer by age. Retrieved March 17, 2008, from
    Chan, S., Friedrichs, K., Noel, D., Pintér, T., Van Belle, S., Vorobiof, D., et al. (1999). Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2341-2354.
    Cox, J.L., Holden, J.M., & Sagovsky, R. (1987). Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782-786.
    Davidson, M., Ladewig, P.A., & London, M.L. (2008). Maternal-newborn nursing and women's health across the lifespan. Upper Saddle River, NJ: Prentice Hall.
    De Santis, M., Lucchese, A., De Carolis, S., Ferrazani, S., & Caruso, A. (2000). Metastatic breast cancer in pregnancy: First case of chemotherapy with docetaxel. European Journal of Cancer Care. 9(4), 235-237.
    Dow, K.H. (2000). Pregnancy and breast cancer. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 29(6), 634-640.
    Espié, M., & Cuvier, C. (1998). Treating breast cancer during pregnancy. What can be taken safely? Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 18(2), 135-142.
    Fanale, M.A., Uyei, A.R., Theriault, R.L., Adam, K., & Thompson, R.A. (2005). Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clinical Breast Cancer, 6(4), 354-356.
    Gainford, M.C., & Clemons, M. (2006). Breast cancer in pregnancy: Are taxanes safe? Clinical Oncology, 18(2), 159.
    Giacalone, P.L., Laffargue, F., & Bénos, P. (1999). Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer, 86(11), 2266-2272.
    Giannakopoulou, C., Manoura, A., Hatzidaki, E., Korakaki, E., Froudarakis, G., & Koumandakis, E. (2000). Multimodal cancer chemotherapy during the first and second trimester of pregnancy: A case report. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 91(1), 95-97.
    Gwyn, K. (2005). Children exposed to chemotherapy in utero. Journal of the National Cancer Institute. Monographs, 34, 69-71.
    Gwyn, K., & Theriault, R. (2001). Breast cancer during pregnancy. Oncology, 15(1), 39-46.
    Jones, S.E., Erban, J., Overmoyer, B., Budd, G.T., Hutchins, L., Lower, E., et al. (2005). Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. Journal of Clinical Oncology, 23(24), 5542-5551.
    Kal, H., & Struikmans, H. (2005). Radiotherapy during pregnancy: Fact and fiction. Lancet Oncology, 6(5), 328-333.
    Keleher, A.J., Theriault, R.L., Gwyn, K.M., Hunt, K.K., Stelling, C.B., Singletary, S.E., et al. (2002). Multidisciplinary management of breast cancer concurrent with pregnancy. Journal of the American College of Surgeons, 194(1), 54-64.
    Lehne, R. (2007). Pharmacology for nursing care. St. Louis, MO: Saunders-Elsevier.
    Logue, K. (2009). Pregnancy associated breast cancer. Clinical Journal of Oncology Nursing, 13(1), 25-27.
    Matthews, T.J., & Hamilton, B.E. (2002). Mean age of mother, 1970-2000. National Vital Statistics Report, 51(1), 2-16.
    Mayo Clinic. (2007). Fetal development: What happens during the first trimester. Retrieved March 31, 2008, from
    Nabholtz, J.M., Senn, H.J., Bezwoda, W.R., Melnychuk, D., Deschěnes, L., Douma, J., et al. (1999). Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. Journal of Clinical Oncology, 17(5), 1413-1424.
    National Cancer Institute. (2008). Breast cancer treatment and pregnancy. Retrieved March 8, 2008, from
    National Cancer Institute. (2005). Docetaxel combo effective after surgery for node-positive breast cancer. Retrieved April 15, 2009, from
    National Center for Health Statistics. (2008). Birth data. Retrieved April 10, 2008, from
    Nieto, Y., Santisteban, M., Aramendía, J.M., Fernández-Hidalgo, O., García-Manero, M., & López, G. (2006). Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clinical Breast Cancer, 6(6), 533-534.
    Nonacs, R. (2007). Postpartum depression. Retrieved December 1, 2008, from
    Peters, B.G., Bray, J.J., Masidonski, P., & Mahon, S.M. (2001). Issues surrounding adjuvant chemotherapy for breast cancer during pregnancy. Oncology Nursing Forum, 28(4), 639-642.
    Petrek, J.A., Dukoff, R., & Rogatko, A. (1991). A prognosis of pregnancy-associated breast cancer. Cancer, 67(4), 869-872.
    Piccart, M.J., Klijn, J., Paridaens, R., Nooij, M., Mauriac, L., Coleman, R., et al. (1997). Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: Final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. Journal of Clinical Oncology, 15(9), 3149-3155.
    Potluri, V., Lewis, D., & Burton, G.V. (2006). Chemotherapy with taxanes in breast cancer during pregnancy. Clinical Breast Cancer, 7(2), 167-170.
    Psyrri, A., & Burtness, B. (2005). Pregnancy-associated breast cancer. Cancer Journal, 11(2), 83-95.
    Sabate, J.M., Clotet, M., Torrubia, S., Gomez, A., Guerrero, R., de las Heras, P., et al. (2007). Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics, 27(1, Suppl.), S101-S124.
    Sekar, R., & Stone, P.R. (2007). Trastuzumab use for metastatic breast cancer in pregnancy. Obstetrics and Gynecology, 110(2), 507-510.
    Shrim, A., Garcia-Bournissen, F., Maxwell, C., Farine, D., & Koren, G. (2007). Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy—Case report and updated literature review. Reproductive Toxicology, 23(4), 611-613.
    Sjöström, J., Blomqvist, C., Mouridsen, H., Pluzanska, A., Ottosson-Lönn, S., Bengtsson, N.O., et al. (1999). Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: A randomised phase III study with crossover on progression by the scandinavian breast group. European Journal of Cancer, 35(8), 1194-1201.
    Turchi, J.J., & Villasis, C. (1988). Anthracyclines in the treatment of malignancy in pregnancy. Cancer, 61(3), 435-440.
    Waterston, A.M., & Graham, J. (2006). Effect of adjuvant trastuzumab on pregnancy. Journal of Clinical Oncology 24(2), 321-322.
    Watson, W.J. (2005). Herceptin (trastuzumab) therapy during pregnancy: Association with reversible anhydramnios. Obstetrics and Gynecology, 105(3), 642-643.
    Woo, J.C., Yu, T., & Hurd, T.C. (2003). Breast cancer in pregnancy: A literature review. Archives of Surgery, 138(1), 91-98.
    Yang, W.T., Dryden, M.J., Gwyn, K., Whitman, G.J., & Theriault, R. (2006). Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology, 239(1), 52-60.
    Yin, R.K. (1999). Enhancing the quality of case studies in health services research. Health Services Research, 34(5), 1209-1224.
    U.S. Food and Drug Administration. (2002). Pregnancy categories. Retrieved July 10, 2009, from
    U.S. Food and Drug Administration. (2009). FDA resources for women. Retrieved April 15, 2009, from
    Zemlickis, D., Lishner, M., Degendorfer, P., Panzarella, T., Burke, B., Sutcliffe, S.B., et al. (1992). Maternal and fetal outcome after breast cancer in pregnancy. International Journal of Gynecology and Obstetrics, 39(3), 252-252.